At two weeks after injection:-Decrease in renal fibrosis, vacuole degeneration, inflammatory cell infiltrate, and interstitial fibrosis-Decrease in Il-6, IL-1β, and TNF-α-Increase epidermal growth factor, fibroblast growth factor, and vascular endothelial growth factor. The gene discussed is VEGFA; the disease is renal fibrosis.